Komori
Fuji Pharma (4554) · InitiativeRestated

Enterprise-Wide Risk Management by the Risk Management Committee and Internal Audit

First written in FY2017. 2 of 4 entries say "Advanced", first in FY2020. Latest entry: FY2022.

4entries
6years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2017AdvancedFY2020 – FY20212017: 12018: 020182019: 020192020: 120202021: 120212022: 12022
Same theme, other companies
Company-Wide Risk Management Framework through Audit and Internal ControlA theme 527 companies write about · 2 as a headwind · 523 as a tailwind
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 197 companies compared. The sentences above are computed from all 197.Comparing 200 of the theme's 534 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2022RestatedAnnual report

    「Each year, the relevant departments conduct tabletop exercises covering multiple of the 17 types of crisis, identify issues and take steps to address them.」

    The company continues to conduct tabletop exercises covering the 17 types of crisis, identify issues and address them.
  2. FY2021AdvancedAnnual report

    「Each year, the relevant departments conduct tabletop exercises covering multiple of the 17 types of crisis, identify issues and take steps to address them.」

    In addition to establishing response procedures for each of the 17 types of crisis, the company has put in place an operational framework for conducting tabletop exercises covering multiple types each year.
  3. FY2020AdvancedAnnual report

    「In addition, the Risk Management Committee has prepared response procedure sheets for crisis events, established response procedures for each of 17 crises and communicated them throughout the company.」

    Describes progress in establishing and communicating specific management procedures for each of the 17 types of crisis, in addition to risk assessments by the Risk Management Committee.
  4. FY2017First statedAnnual report

    「Based on the Enterprise-Wide Risk Management Regulations, the Risk Management Committee conducts risk assessments, develops an enterprise-wide risk management framework and identifies issues. The Internal Audit Office audits the risk management status of each department and reports the results to the president.」

    Describes an enterprise-wide risk management system combining the regulations, the Risk Management Committee and the Internal Audit Office.
Moved together

"Early development and launch of new drugs, biosimilars and value-added generics" moved the same way as this thread, in the same document, in 2 of its 4 moves.

2222★1234
  1. ★This thread
  2. 1Early development and launch of new drugs, biosimilars and value-added generics2×
  3. 2Enhancing the Development Pipeline through Strategic Alliances with Companies in Japan and Overseas2×
  4. 3Review of Strategic Shareholdings Based on Medium- to Long-Term Enhancement of Corporate Value2×
  5. 4Investment in Production Facilities to Ensure High Quality and Stable Supply2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Fuji Pharma yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Enterprise-Wide Risk Management by the Risk Management Committee and Internal Audit | Fuji Pharma Co.,Ltd. (4554) | Komori